(13-272) Retrospective Cost Analysis of Potential Use of Intramuscular or Subcutaneous Calcitonin in Place of Denosumab for Inpatient Treatment of Hypercalcemia of Malignancy
Wednesday, December 10, 2025
3:15 PM - 4:15 PM
Location: Bayside A, Level 1
Residency Program: Kadlec Regional Medical Center Residency Program Type: PGY1 (Pharmacy) Residency Program Location: Washington
